www.hivandhepatitis.com

Skip to content

Back HCV Treatment

EASL 2015: Patients Who Fail Short Course of Sofosbuvir/Ledipasvir Can Be Cured with 24 Weeks

Details: Category: HCV Treatment; Published on Thursday, 30 April 2015 00:00; Written by Liz Highleyman

More than 70% of genotype 1 chronic hepatitis C patients who did not achieve sustained virological response when treated with sofosbuvir/ledipasvir (Harvoni) for 8 or 12 weeks were cured with a subsequent 24-week course of the same 2 drugs, according to a study presented at the European Association for the Study of the Liver (EASL) 50th International Liver Congress last week in Vienna.

alt

Subcategories

Page 150 of 643

Hepatitis C Topics

Web Design and Development by Bread and Roses Web Design

	The Liver Meeting (AASLD 2017) October 20-24, 2017, Washington, DC
	6th European AIDS Conference (EACS 2017) October 20-27, 2017, Milan
	9th IAS Conference on HIV Science (IAS 2017) July 23-26, 2017, Paris
	2017 Harm Reduction International Conference May 14-17, 2017, Montreal
	2017 Pediatric Academic Societies Meeting May 6-9, 2017, San Francisco
	2017 EASL International Liver Congress April 19-23, 2017, Amsterdam
	2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) February 13-16, 2017, Seattle
	The Liver Meeting (AASLD 2016) November 11-15, 2016, Boston
	IDWeek 2016 October 26-30, 2016, New Orleans
	HIV Drug Therapy 2016 October 23-26, 2016, Glasgow
	HIV Research for Prevention (HIVR4P 2016) October 17-21, 2016, Chicago
	5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) Sept 7-9, 2016, Oslo
	21st International AIDS Conference (AIDS 2016) July 18-22, 2016, Durban
	ASM Microbe 2016/ICAAC 2016 June 16-20, 2016, Boston
	2016 EASL International Liver Congress April 13-17, 2016, Barcelona
	2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016) February 22-25, 2016, Boston
	2015 National HIV Prevention Conference (NHPC 2015) December 6-9, 2015, Atlanta
	46th Union World Conference on Lung Health December 2-6, 2015, Cape Town
	The Liver Meeting (AASLD 2015) November 13-17, 2015, San Francisco
	15th European AIDS Conference (EACS 2015) October 21-24, 2015, Barcelona
	24th International Harm Reduction Conference (IHRC 2015) October 18-21, 2015, Kuala Lumpur
	IDWeek 2015 October 7-11, 2015, San Diego
	4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015) October 7-9, 2015, Sydney
	55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2015) September 17-21, 2015, San Diego
	8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2015) July 19-22, 2015, Vancouver
	Digestive Disease Week 2015 May 16-19, 2015, Washington, DC
	50th International Liver Congress (EASL 2015) April 22-26, 2015, Vienna
	21st Annual Meeting of the British HIV Association (BHIVA) April 21-24, 2015, Brighton
	2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015) February 23-26, 2015, Seattle

www.hivandhepatitis.com

Syndicate Feeds

EASL 2015: Patients Who Fail Short Course of Sofosbuvir/Ledipasvir Can Be Cured with 24 Weeks

Subcategories

Hepatitis C Topics

CONFERENCE COVERAGE